cytarabine [clinicaltrials_resource:365f8fcdfa69d1c55e8c02dc0fbdea6f]
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [clinicaltrials:NCT00004862]
intervention [clinicaltrials_vocabulary:intervention]
cytarabine [clinicaltrials_resource:365f8fcdfa69d1c55e8c02dc0fbdea6f]
Bio2RDF identifier
365f8fcdfa69d1c55e8c02dc0fbdea6f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:365f8fcdfa69d1c55e8c02dc0fbdea6f
arm group [clinicaltrials_vocabulary:arm-group]
intervention name [clinicaltrials_vocabulary:intervention-name]
cytarabine
identifier
clinicaltrials_resource:365f8fcdfa69d1c55e8c02dc0fbdea6f
title
cytarabine
@en
type
label
cytarabine [clinicaltrials_resource:365f8fcdfa69d1c55e8c02dc0fbdea6f]
@en